Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct 13;16(10):1460.
doi: 10.3390/ph16101460.

Radiometals in Imaging and Therapy: Highlighting Two Decades of Research

Affiliations
Review

Radiometals in Imaging and Therapy: Highlighting Two Decades of Research

Shalini Sharma et al. Pharmaceuticals (Basel). .

Abstract

The present article highlights the important progress made in the last two decades in the fields of molecular imaging and radionuclide therapy. Advancements in radiometal-based positron emission tomography, single photon emission computerized tomography, and radionuclide therapy are illustrated in terms of their production routes and ease of radiolabeling. Applications in clinical diagnostic and radionuclide therapy are considered, including human studies under clinical trials; their current stages of clinical translations and findings are summarized. Because the metalloid astatine is used for imaging and radionuclide therapy, it is included in this review. In regard to radionuclide therapy, both beta-minus (β-) and alpha (α)-emitting radionuclides are discussed by highlighting their production routes, targeted radiopharmaceuticals, and current clinical translation stage.

Keywords: imaging; positron emission tomography; radiometals; radionuclide therapy; single photon emission computerized tomography.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Comparison of beta and alpha radionuclide therapies.
Scheme 1
Scheme 1
Decay scheme for various radionuclides.
Scheme 2
Scheme 2
Decay scheme for various α-emitting radionuclides.

Similar articles

Cited by

References

    1. Gianfaldoni S., Gianfaldoni R., Wollina U., Lotti J., Tchernev G., Lotti T. An Overview on Radiotherapy: From Its History to Its Current Applications in Dermatology. Open Access Maced. J. Med. Sci. 2017;5:521–525. doi: 10.3889/oamjms.2017.122. - DOI - PMC - PubMed
    1. Lederman M. The early history of radiotherapy: 1895–1939. Int. J. Radiat. Oncol. Biol. Phys. 1981;7:639–648. doi: 10.1016/0360-3016(81)90379-5. - DOI - PubMed
    1. Pusey W.A. Roentgen rays in the treatment of skin diseases and for the removal of hair. J. Cutan. Dis. Incl. Syph. 1900;18:302–318. doi: 10.1001/archderm.1983.01650260070022. - DOI
    1. Chen H.H.W., Kuo M.T. Improving radiotherapy in cancer treatment: Promises and challenges. Oncotarget. 2017;8:62742–62758. doi: 10.18632/oncotarget.18409. - DOI - PMC - PubMed
    1. Jones P.M. Treatment of lupus by x-rays. Phila. Med. J. 1900;5:63–64.

LinkOut - more resources